NCT00221676View on ClinicalTrials.gov

Effectiveness of Influenza Vaccination Among General Practitioners

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

June 30, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

Alfarix

Sponsors

Collaborators (1)

Eurogenerics NV
All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

collaborator

Eurogenerics NV

INDUSTRY

lead

University Hospital, Antwerp

OTHER